Video

Vitamin D Deficiencies Can Impact Myeloma Outcomes

A lack of vitamin D can have major impacts on myeloma treatment outomes.

Most people do not think about their vitamin D intake, but Chloe Spear, BSN, RN, OCN, knows that it is important — especially for patients with myeloma.

Spear, clinical specialty coordinator in the Myeloma Program at Mount Sinai, conducted a study examining the effects that a vitamin D deficiency can have on outcomes for patients with myeloma. She hopes to turn her findings — that patients with deficiencies have poorer prognoses – into a standard-of-care for treating patients who come into the clinic with vitamin D deficiencies. Intervention would be fairly simple and straightforward: prescribing patients with oral vitamin D supplements to take daily.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of doctor.
Image of man with black hair.
Picture of Dr. Pouneh Razavi
Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Anne M. Reb is a nurse practitioner with City of Hope.
Related Content